throbber
Biochemical Pharmacology, Vol. 39, No. 10, pp. 1597-1601, 1990.
`Printed in Great Britain.
`
`0006-2952/90 $3.00 + 0.00
`© 1990. Pergamon Press pic
`
`COMPARATIVE EVALUATION OF THE ANTIOXIDANT
`ACTIVITY OF a-TOCOPHEROL, a-TOCOPHEROL
`POLYETHYLENE GLYCOL 1000 SUCCINATE AND
`a-TOCOPHEROL SUCCINATE IN ISOLATED HEP ATOCYTES
`AND LIVER MICROSOMAL SUSPENSIONS
`
`RITA CARINI,* GIUSEPPE Pou,* MARIO U. DIANZANI,* SUSAN P. MADDIX,t TREVOR F.
`SLATERt and KEVIN H. CHEESEMANH
`*Department of Experimental Medicine and Oncology, University of Turin, Corso Raffaello. 30, 10125
`Turin, Italy and tDepartment of Biology and Biochemistry, Brunei University, Uxbridge, Middlesex
`UB8 3PH, U.K.
`
`(Received 27 October 1989; accepted 2 January 1990)
`
`Abstract-The antioxidant activity of a-tocopherol polyethylene glycol 1000 succinate (TPGS) and of
`a-tocopherol succinate (TS) has been examined in isolated hepatocytes and microsomal fractions from
`rat liver. Both TPGS and TS require esterase activity to yield free a-tocopherol and, hence, antioxidant
`activity. TPGS and TS consistently exerted a more effective antioxidant protection than an equivalent
`amount of directly-added free a-tocopheroL The low antioxidant efficiency of directly added free a(cid:173)
`tocopherol in such water-based experimental systems as used here seems to be due to its extreme
`hydrophobicity. TPGS, on the other hand, is an extremely hydrophilic compound that is being examined
`as a useful source of a-tocopherol in certain clinical situations and is here shown to be a convenient and
`effective source for experimental studies into lipid peroxidation and antioxidant mechanisms.
`
`The role of free radical mediated reactions such as
`lipid peroxidation in a wide range of tissue injuries
`is a subject of great current interest. One of the main
`experimental approaches to investigate the role of
`such mechanisms in a given model of tissue injury is
`the use of antioxidant free radical scavenging com(cid:173)
`pounds as putative protective agents. Since a-toc(cid:173)
`opherol is the major lipid-soluble chain-breaking
`antioxidant in biological systems [1, 2] it is the pro(cid:173)
`tective agent of choice in model systems where lipid
`peroxidation of cell membranes is under inves(cid:173)
`tigation. Modulation of the membrane levels of a(cid:173)
`tocopherol is not straightforward, however. Deple(cid:173)
`tion of cell membrane a-tocopherol can be achieved
`by feeding a deficient diet over a period of up to 15
`weeks. Enrichment of liver cell membranes with a(cid:173)
`tocopherol can be achieved by i.p. injection of a
`large dose of the compound before killing the animal
`[2, 3] but this technique is quantitatively unpre(cid:173)
`dictable however, and is altogether rather unwieldy.
`The direct addition of a-tocopherol to isolated cells
`or cell membrane suspensions in vitro would be a far
`more convenient way of investigating the antioxidant
`effects of this compound in many experimental
`model systems. Unfortunately, the extreme hydro(cid:173)
`phobicity of a-tocopherol makes the reproducible
`direct addition of it to water-based systems such as
`suspensions of cells or cell membranes very difficult.
`Using this method, a-tocopherol added to these sys(cid:173)
`tems is generally much less efficient as an antioxidant
`
`:j: Correspondence should be addressed to: Dr K. H.
`Cheeseman, Department of Biology and Biochemistry,
`Brunei University, Uxbridge, Middlesex UB8 3PH, U.K.
`
`than endogenous a-tocopherol. The poor anti(cid:173)
`oxidant effect of a-tocopherol added to aqueous
`suspensions of cells and cell membranes seems to be
`due to an uneven dispersion that prevents its efficient
`dissolution in the cell membranes.
`Esters of a-tocopherol that are more hydrophilic
`are available: a-tocopherol succinate (TS) is often
`used in tissue culture media and for direct addition
`to primary incubations of cells. Also available is a(cid:173)
`tocopheryl polyethylene glycol 1000 succinate
`(TPGS) that has been the subject of little exper(cid:173)
`imental attention but which has recently been shown
`to be very useful as a source of vitamin E in children
`with cholestasis who are unable to absorb normal
`dietary vitamin E because of the absence of bile
`salts [4-6]. TPGS, and possibly TS, may also be
`convenient sources of a-tocopherol in experimental
`studies in vitro. TS is still a very hydrophobic com(cid:173)
`pound but TPGS is extremely water-soluble; both
`compounds require de-esterification to reveal the
`free phenol group that is necessary for antioxidant
`activity. In the present paper we have investigated
`the antioxidant activity of TS and TPGS in direct
`comparison with a-tocopherol in isolated hepa(cid:173)
`tocytes and in suspensions of liver microsomes.
`
`MATERIALS AND METHODS
`
`Male Wistar rats, 200-250 g body wt, were
`obtained from Nossan (Correzzana, Italy). They
`were fed on semi-synthetic diet containing 40 I. U.
`of a-tocopherol and 12,000 I.U. of vitamin A/kg,
`with free access to water. Collagenase type I, a(cid:173)
`tocopheryl
`succinate
`(TS)
`and
`bis-(p(cid:173)
`nitrophenyl)phosphate (BNPP) were obtained from
`
`1597
`
`Par Pharm., Inc.
`Exhibit 1010
`Page 001
`
`

`
`1598
`
`R. CARINI et a/.
`
`~~
`~I l
`1~1/
`"' ~~~
`~~
`
`i
`
`!!J.
`9
`Q)
`(.)
`0
`8
`~ 7
`<.i
`~ 6
`"'
`5
`.c
`c.
`(ij 4
`3
`CD
`0
`E 2
`0 c
`"'
`c
`
`the Sigma Chemical Co. (St. Louis, MO). Alpha(cid:173)
`tocopheryl polyethylene glycol 1000 succinate
`(TPGS) was a gift of Eastman Kodak Co. (Roch(cid:173)
`ester, NY). Hepatocytes were isolated by the col(cid:173)
`lagenase perfusion technique described in [7, 8] with
`minor modifications in order to preserve the glu(cid:173)
`tathione content of the cells [9). Liver cell sus(cid:173)
`pensions (5 x 106 cells/mL) were incubated at 37° in
`stoppered 50 mL flasks in a final volume of 1-2.5 mL
`in a buffered medium [7) at pH 7.4. The a-tocopherol
`content of hepatocytes was evaluated after 30, 60,
`120 and 240 min incubations in the presence of either
`free a-tocopherol, TPGS or TS (each at 100 ttM).
`Alpha-tocopherol and TS were added to the cell
`suspension dissolved in dimethyl sulphoxide (final
`concentration 14 mM), while TPGS was diluted in
`water. Lipid peroxidation was measured as MDA
`production using the TBA test [8) after 1 hr incu(cid:173)
`bation with ADP/iron (2.5 mM/100 ttM) or cumene
`hydroperoxide (200 ttM), or 2 hr incubation with
`CC14 (172 ttM) in presence of free a-tocopherol,
`TPGS or TS (each at 100 ttM) with or without pre(cid:173)
`incubation. The effect of bis-p-nitro-phenyl-phos(cid:173)
`phate (BNPP), an inhibitor of non-specific esterases
`was studied by adding to the hepatocytes 25 ttM
`of the compound 10 min before preincubation and
`incubation procedures.
`Liver microsomes were prepared as described pre(cid:173)
`viously [10) and washed once in 0.15 M KCl. Micro(cid:173)
`somal ascorbate/iron dependent lipid peroxidation
`was evaluated as MDA production using the TBA
`test [8]: microsomes (1.5 mg protein/mL) were pre(cid:173)
`incubated for 30 min with 100 ttM free a-tocopherol
`or a-tocopherol esters followed by 10 min incubation
`with ascorbate-iron (500 ttM/5 ttM) in a system con(cid:173)
`taining 37 mM KCl and 49 mM Tris buffer at pH 7 .4.
`Hepatocyte a-tocopherol was extracted and
`measured essentially as described in [1]. Aliquots of
`hepatocyte suspension were washed once with the
`incubation medium and then mixed with 2 mL of
`100 mM SDS, 4 mL of absolute ethanol and 1 mL of
`n-heptane. After vortex-mixing and a brief cen(cid:173)
`trifugation, then-heptane layer was taken for HPLC
`analysis [1]. TPGS and TS did not interfere with this
`assay. Microsomal proteins were determined by the
`method of Lowry eta!. [11].
`
`RESULTS AND DISCUSSION
`
`The use of a-tocopherol in water-based exper(cid:173)
`imental models is fraught with problems and it is
`often observed that it has very low antioxidant
`activity when added exogenously in comparison with
`a-tocopherol
`that
`is
`endogenously
`present.
`Examples of this are seen in the papers of Cadenas
`et al. [12] and Cheeseman et al. [2] where the effect of
`a-tocopherol added to liver microsomal suspensions
`stimulated to peroxidise by ascorbate-iron and by
`NADPH/ ADP-iron, respectively, was found to be
`much lower than that of a-tocopherol already incor(cid:173)
`porated into the membrane. Since there is no doubt
`that a-tocopherol is an extremely efficient anti(cid:173)
`oxidant it must be concluded that in such systems a(cid:173)
`tocopherol is not incorporated into the membrane in
`a way that permits interaction with lipid peroxyl
`radicals. This may be a consequence of the extremely
`
`30
`
`180
`
`120
`60
`incubation time (min.)
`Fig. 1. Time course for the uptake of free a-tocopherol (e)
`TPGS (.&)and TS (•) by isolated rat hepatocytes measured
`as free a-tocopherol by HPLC. All additions were 100 11M.
`Endogenous a-tocopherol (0.799 ± 0.076 nmol/106 cells)
`was subtracted from each value. Values are means of 3-5
`experiments ±SE.
`
`hydrophobic a-tocopherol molecules aggregating
`upon addition to water to yield micelles external
`to the membrane bilayer. In this paper we have
`investigated the possibility of using less hydrophobic
`derivatives of a-tocopherol as more convenient and
`efficient sources of a-tocopherol for experimental
`models in vitro such as suspensions of isolated cells
`or sub-cellular membrane fractions.
`Reed et at. [13-15] have been foremost in inves(cid:173)
`tigating the role of a:-tocopherol on protecting hepa(cid:173)
`tocytes from oxidative stress. In those studies Reed
`et al. have mostly used TS as an exogenous a:-toc(cid:173)
`opherol source and demonstrated that it can afford
`protection against chemical toxicity. A key point of
`their studies has been the critical importance of the
`external calcium concentration in modulating the TS
`effect and a recent publication [16] has emphasised
`this; in our study the calcium concentration was
`always 1 mM. In considering the value of the esters
`TPGS and TS as exogenous a-tocopherol sources,
`we have examined (a) their efficiency in supplying
`free a:-tocopherol to target cells and cell membranes
`and (b) their efficiency as antioxidants (or, more
`properly, antioxidant precursors) in several pro-oxi(cid:173)
`dant systems.
`When isolated hepatocytes are incubated with free
`a-tocopherol, TPGS or TS, a
`time-dependent
`increase in the free a:-tocopherol content of the cells
`as measured by HPLC was observed (Fig. 1). These
`data should represent, in the case of direct addition
`of free a-tocopherol addition, the actual uptake of
`a-tocopherol by the cells and, in the case of TPGS
`and TS addition, the release of free a-tocopherol
`into the cells by the action of esterases. The ability
`of the intact TPGS molecule to enter cells has been
`demonstrated by Traber et al. [8] using human fibro(cid:173)
`blasts, erythrocytes and an intestinal cell line. Thus
`TPGS may be taken up by hepatocytes as the intact
`molecule and hydrolysed to free a-tocopherol within
`the cell. The rate of a-tocopherol appearance in the
`cells tended to be slower using TPGS or TS compared
`to direct addition of free a-tocopherol (e.g. at 60 min
`incubation) but after 3 hr of incubation these dif(cid:173)
`ferences were not appreciable. It is also apparent
`
`Par Pharm., Inc.
`Exhibit 1010
`Page 002
`
`

`
`Antioxidant activity of water-soluble a-tocopherol esters
`
`1599
`
`Table 1. MDA production stimulated in isolated hepatocytes by ADP-iron, CC14 or cumene hydro(cid:173)
`peroxide and the antioxidant effect of the addition of free a-tocopherol, TGPS or TS (each 100 ,uM)
`with and without pre-incubation
`
`nmols MDA/106 cells(% inhibition)
`
`Treatment
`
`ADP-iron
`
`CC14
`
`Cumene hydroperoxide
`
`Control
`Free a-tocopherol
`With pre-incubation
`Without pre-incubation
`TPGS
`With pre-incubation
`Without pre-incubation
`TS
`With pre-incubation
`Without pre-incubation
`
`4.31 ± 0.31
`3.45 ± 1.o4 (20% )II
`3.50 ± 0.15 (19%)11
`
`1.68 ± 0.08
`
`2.50 ± 0.23
`
`1.05 ± 0.07 (38% ):j:
`0.74 ± 0.31 (56% ):j:
`
`1.48 ± 0.40(41%)§
`2.03 ± o.3o (19% )II
`
`1.52 ± 0.33 (65% )*
`2.50 ± 0.08 ( 42% )§
`
`0.41 ± 0.07 (76% )*
`0.47 ± 0.04 (72% )*
`
`0.77 ± 0.29 (69%)*
`1.12 ± 0.25 (55% )t
`
`1.98 ± 0.35 (54% ):j:
`2.57 ± 0.12 (40%)§
`
`0.70 ± 0.12 (58%)§
`0.39 ± 0.01 (77% ):j:
`
`0.70 ± 0.18 (72%)*
`1.22 ± 0.24 (51% ):j:
`
`The pre-incubation time was 1 hr, incubation with ADP-iron or cumene hydroperoxide was for a
`further 1 hr and with CC14 for a further 2 hr. Values in parentheses are% inhibition relative to controls.
`Values are means ± SE of 8-12 experiments. Statistical significance of difference relative to control
`(Student's t-test): • P < 0.001; t P < 0.002; :j: P <0.01; § P < 0.05; II not significantly different.
`
`that, in all cases, after 3 hr of incubation the hep(cid:173)
`tocytes were able to accumulate nearly 50% of the
`total available a-tocopherol
`in
`the
`incubation
`medium.
`All three compounds afforded some degree of
`antioxidant effect and with all three pro-oxidant
`systems (Table 1). With the tocopherol esters, pre(cid:173)
`incubation (60 min) allowed a significantly greater
`antioxidant effect than did simultaneous addition,
`except in the case of the CC14 system. This enhance(cid:173)
`ment of effectiveness by pre-incubation was not seen
`with the addition of free a-tocopherol. With or with(cid:173)
`out pre-incubation and with all three antioxidant
`forms the CC14 dependent system was consistently
`the most sensitive to inhibition, possibly because it
`exhibited the lowest pro-oxidant activity.
`TPGS and TS consistently provided better pro(cid:173)
`tection against lipid peroxidation than the equivalent
`concentration of free a-tocopherol despite that (at
`least at the beginning of the incubation) less free (and
`therefore active) a-tocopherol would be available in
`the cells. In hepatocytes, depending on which pro(cid:173)
`oxidant stimulus was used, TPGS was 1.3 to 2.9
`times more effective than free a-tocopherol without
`pre-incubation and 1. 7 to 3.3 times more effective
`with pre-incubation. TS was 1.2 to 2.7 times more
`effective than free a-tocopherol without pre-incu(cid:173)
`bation. In hepatocytes TPGS tended to be more
`effective than TS.
`In liver microsomal suspensions the better anti(cid:173)
`oxidant protection afforded by the tocopherol esters
`relative to directly added free a-tocopherol is even
`more striking (Table 2). With 30 min pre-incubation
`TPGS inhibits ascorbate-iron dependent lipid per(cid:173)
`oxidation by 68%, TS inhibits by 47% and free
`a-tocopherol inhibits by a mere 3%. Microsomes
`clearly possess an esterase active towards the toc(cid:173)
`opherol esters since this esterase activity is essential
`for the antioxidant activity of the tocopherol esters
`to be realised by release of the free a-tocopherol.
`Hence, in liposomes TPGS has no antioxidant
`activity (data not shown). The importance of esterase
`
`Table 2. MDA production by rat liver microsomes incu(cid:173)
`bated for 10 min with ascorbate iron (500 ,uM/5 ,uM) after
`30 min pre-incubation with or without a-tocopherol, TPGS
`or TS, each at 100 ,uM. Values in parenthesis are % inhi-
`bition relative to control
`
`Control
`+ a-tocopherol
`+ TPGS
`+ TS
`
`nmol/min/mg
`protein
`
`1.15 ± 0.27
`1.12 ± 0.31 (3% )*
`0.37 ± 0.11 (68% )t
`0.61 ± 0.26 ( 47% )*
`
`Values are means of three experiments in duplicate ±SE.
`• Not significant compared to the control (Student's t(cid:173)
`test).
`t Significant compared to the control (Student's t-test;
`p < 0.05).
`
`activity is also evident from experiments using the
`esterase inhibitor BNPP in isolated hepatocytes.
`After BNPP treatment the hepatocytes converted
`much less of the tocopherol esters to free a-toc(cid:173)
`opherol and reduced their antioxidant efficacy to
`non-significant levels (Table 3).
`Paradoxically, it is clear that TPGS and TS con(cid:173)
`sistently exerted a more effective antioxidant pro(cid:173)
`tection than an equivalent amount of directly added
`free a-tocopherol. It seems likely that the apparent
`lack of activity of directly-added free a-tocopherol
`may be due in some way to its extreme hydro(cid:173)
`phobicity. We envisage that addition of a-tocopherol
`to a water-based system such as a suspension of
`cells or microsomes leads to aggregation of the a(cid:173)
`tocopherol molecules in a micellar form with certain
`physico-chemical characteristics that prevent incor(cid:173)
`poration of the a-tocopherol in the cell membrane
`in an active configuration. From the data shown in
`Fig. 1 it is evident that directly added free a-toc(cid:173)
`opherol is taken up by the cells and at certain time(cid:173)
`points is actually present at concentrations higher
`
`Par Pharm., Inc.
`Exhibit 1010
`Page 003
`
`

`
`1600
`
`R. CARINI et a/.
`
`Table 3. a-Tocopherol levels and ADP-iron-dependent MDA production in isolated rat hepatocytes
`after pre-incubation with TPGS or TS: effect of bis-(p-nitro-phenyl) phosphate (BNPP)
`
`a-Tocopherol
`
`Lipid peroxidation/(% inhibition)
`
`without BNPP
`
`with BNPP
`
`without BNPP
`
`with BNPP
`
`Control
`+TPGS
`+ TS
`
`0.80 ± 0.08
`2.89 :±: 0.34*
`3.20 :±: 0.55t
`
`0.56 :±: 0.27
`0.96 ± 0.28:j:
`0.79 ± 0.29:j:
`
`4.31 :±: 0.31
`1.52 ± 0.33 (65% )*
`1. 98 ± 0.35 (54% )t
`
`4.98 :±: 0.49
`4.07 :±: 0.24 (18% ):j:
`3.88 ± 0.23 (22%):j:
`
`Results are nmoles of a-tocopherol or MDA per 106 cells and (in parentheses) percentage inhibition
`of lipid peroxidation by tocopherol esters; they are the mean values ( ±SE) from three experiments.
`Student's t-test: * P < 0.001; t P < 0.01; + no significant difference compared to the control.
`Hepatocytes were treated for 10 min with 25 ,uM BNPP, pre-incubated for 1 hr with 100 ,uM a(cid:173)
`tocopherol esters and then incubated for 1 hr with ADP-iron (2.5 ,uM/0.1 ,uM) at which time lipid
`peroxidation was measured as MDA production.
`
`than that of a-tocopherol derived from the esters. It
`must be deduced that the directly-added a-toc(cid:173)
`opherol is either not in the right location or not in
`an active configuration in the membrane. In the
`former case one may imagine that free a-tocopherol
`added directly to hepatocytes could accumulate in a
`cell membrane not undergoing lipid peroxidation
`while the opposite may be true for TPGS and TS.
`This could be due to the tocopherol esterase activity
`being located in the same membrane as that under(cid:173)
`going lipid peroxidation (e.g. endoplasmic retic(cid:173)
`ulum). However, this would not explain the result
`seen with the microsomal suspension where a-toc(cid:173)
`opherol is added directly to the target membrane.
`Thus, it appears that directly added free a-toc(cid:173)
`opherol is associating with or dissolving in the mem(cid:173)
`brane in an inactive configuration, possibly still in
`aggregates. Our data are in accord with those of
`Cadenas et al. [12] who also concluded that a-toc(cid:173)
`opherol added exogenously is ineffective because it
`is not properly incorporated into the membrane.
`Moreover, they postulated that a-tocopherol might
`need to be incorporated into specific sites in the
`membrane, i.e. near to the sites of radical produc(cid:173)
`tion. The efficacy of TPGS and TS might be due
`to the gradual release of a-tocopherol by esterase
`activity at the appropriate site and rate to allow
`dissolution in the membrane in an active con(cid:173)
`figuration, allowing rapid diffusion in the plane of
`the membrane and scavenging of peroxyl radicals.
`rather than forming inactive aggregates.
`Our data are consistent with the recent report of
`Fariss et al. [16] who also found that when adding
`either free a-tocopherol or TS to hepatocytes the
`level of cell protection was greater with TS despite
`that a lower level of unesterified a-tocopherol was
`reached in the cells. They postulate that some cyto(cid:173)
`protective effect might be due to the intact TS mol(cid:173)
`ecule or even the release of succinate. This to us
`appears to be unlikely and we believe the explanation
`presented here for our data is equally applicable to
`their observations.
`Further work is required to understand precisely
`why a-tocopherol is ineffective when added directly
`to aqueous suspensions of cells or cell membranes.
`Meanwhile TPGS is not only finding use in the clini(cid:173)
`cal situation but is also clearly a very convenient and
`
`effective source of active a-tocopherol for hepa(cid:173)
`tocytes and liver microsomes in vitro.
`
`REFERENCES
`
`1. Burton GW, Joyce A and Ingold KU, Is vitamin E the
`only lipid-soluble, chain-breaking antioxidant in human
`blood plasma and erythrocyte membranes? Arch Bio(cid:173)
`chem Biophys 221: 281-290, 1983.
`2. Cheeseman KH, Collins M, Proudfoot KP, Slater TF,
`Burton GW, Webb AC and Ingold KU, Studies on
`lipid peroxidation in normal and tumour tissue. 1. The
`Novikoff rat liver tumour. Biochem J 235: 507-514,
`1986.
`3. Pfeiffer PM and McCay PB, Reduced triphospho(cid:173)
`pyridine nucleotide oxidase-catalysed alterations of
`membrane phospholipids. V. Use of erythrocytes to
`demonstrate enzyme dependent production of a com(cid:173)
`pound with the properties of a free radical. J Bioi Chern
`246: 6401-6408, 1971.
`4. Traber MG, Kayden HJ, Green JB and Green MH,
`Absorption of water-miscible forms of vitamin E in a
`patient with cholestasis and in thoracic-duct-cannulated
`rats. Am J Clin Nutr 44: 914-923, 1986.
`5. Sokol RJ, Hembi JE, Butler-Simon N, McLung HJ,
`Lilly JR and Silverman A, Treatment of vitamin E
`deficiency during chronic childhood cholestasis with
`oral d-a-tocopherol polyethylene glycol-1000 succi(cid:173)
`nate. Gastroenterology 93: 975-985, 1987.
`6. Traber MG, Thellman CA, Rindler MJ and Kayden
`HJ, Uptake of intact TPGS ( d-a-tocopherol poly(cid:173)
`ethylene glycol-1000 succinate), a water-miscible form
`of vitamin E by human cells in vitro. Am J Clin Nutr
`48: 605-611, 1988.
`7. Poli G, GravelaE, Albano E and Dianzani MU, Studies
`on fatty liver with isolated hepatocytes II. Exp Mol
`Patho/30: 116-127, 1979.
`8. Poli G, Cheeseman KH, Slater TF and Dianzani MU,
`The role of lipid peroxidation in CC14 induced damage
`to liver microsomal enzymes: comparative studies in
`vitro using microsomes and isolated liver cells. Chern
`Bioi Interact 37: 13-24, 1981.
`9. Vina J, Hems Rand Krebs HA, Maintenance of glu(cid:173)
`tathione content in isolated hepatocytes. Biochem J
`170: 627-630, 1978.
`10. Slater TF and Sawyer BC, The effects of CC14 on rat
`liver microsomes during the first hour of poisoning
`in vivo and the modifying actions of promethazine.
`Biochem J 111: 317-324, 1969.
`11. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ,
`Protein measurement with the Folin phenol reagent. J
`
`Par Pharm., Inc.
`Exhibit 1010
`Page 004
`
`

`
`Antioxidant activity of water-soluble a-tocopherol esters
`
`1601
`
`Bioi Chern 193: 265-275, 1951.
`12. Cadenas E, Ginsberg M, Rabc U and Sics H, Eval(cid:173)
`uation of a-tocopherol antioxidant activity in micro(cid:173)
`somal lipid peroxidation as detected by low-level
`chemiluminescence. Biochem J 223: 775-779, 1984.
`13. Pascoe GA and Reed DJ, Relationship between cellu(cid:173)
`lar calcium and vitamin E metabolism during protection
`against cell injury. Arch Biochem Biophys 253: 287-
`296, 1987.
`14. Pascoe GA, Fariss MN, Olafsdottir K and Reed DJ, A
`role of vitamin E in protection against cell injury.
`
`Maintenance of intracellular glutathione precursors
`and biosynthesis. Eur J Biochem 166: 241-247, 1987.
`15. Pascoe GA, Olafsdottir K and Reed DJ, Vitamin E
`protection against chemical induced cell injury I. Main(cid:173)
`tenance of cellular protein thiols as a cytoprotective
`mechanism. Arch Biochem Biophys 256: 150-158,
`1987.
`16. Fariss MW, Merson MH and O'Hara TM, a-tocopherol
`succinate protects hepatocytes from chemical induced
`toxicity under physiological calcium conditions. Tox(cid:173)
`icol Lett 41: 61-75, 1989.
`
`Par Pharm., Inc.
`Exhibit 1010
`Page 005

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket